结直肠癌肝转移外科微波消融治疗后的结局
该单中心高容量机构的回顾性研究分析了2006年10月至2022年9月接受外科微波消融的328例结直肠癌肝转移患者共394次手术、842个肿瘤的结局。结果显示30天死亡率为1.2%,Clavien-Dindo III或IV级并发症发生率为3.6%,每肿瘤不完全消融率为1.5%,局部复发率为6.3%,1年生存概率为91%(95%CI 87.9至94.3),平均总生存期为57.6个月(95%CI 49.9至65.4个月)。作者认为外科微波消融是一种低并发症的治疗方法,失败率低。
要点
- 328例患者共接受394次手术,消融842个肿瘤,中位肿瘤大小1.5 cm,中位消融肿瘤数1个。
- Clavien-Dindo III或IV级并发症发生于12例(3.6%),30天内死亡4例(1.2%)。
- 每肿瘤不完全消融率1.5%,局部复发率6.3%,1年生存概率91%(95%CI 87.9至94.3)。
核心结论
- 外科微波消融为结直肠癌肝转移提供了一种低并发症且失败率低的治疗方法。
研究设计与样本
- 单中心高容量机构的回顾性综述,使用前瞻性维护的数据库,纳入2006年10月至2022年9月接受外科微波消融的患者。
- 共实施394次手术,涉及328例患者和842个肿瘤。
- 主要结局为总生存期。
主要发现
- 中位肿瘤大小为1.5 cm(范围0.4至7.0 cm),每次手术中位消融肿瘤数为1个(范围1至11)。
- 77.9%的手术采用腹腔镜入路,63%的手术同时施行其他操作,最常见为肝切除(22.3%)、胆囊切除(17.5%)和结肠切除(6.6%)。
- Clavien-Dindo III或IV级并发症发生于12例患者(3.6%),这些患者均接受了同时施行的操作。
- 30天内死亡发生于4例患者(1.2%)。
- 每肿瘤不完全消融率为1.5%,局部复发率为6.3%,黑人患者的不完全消融和局部复发发生率更高。
关键数值与推荐
- 不完全消融率:每肿瘤1.5%。
- 局部复发率:每肿瘤6.3%。
- 1年生存概率:91%(95%CI 87.9至94.3)。
- 平均总生存期:57.6个月(95%CI 49.9至65.4个月)。
- Clavien-Dindo III或IV级并发症:12例(3.6%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colorectal cancer (CRC) is the third most common cause of cancer mortality worldwide. Of these, approximately 25% will have liver metastasis. We performed 394 microwave ablations (MWAs) and analyzed outcomes for survival and ablation failure. STUDY DESIGN: We conducted a retrospective review of patients who underwent a surgical MWA at a single-center high-volume institution from October 2006 to September 2022 using a prospectively maintained database. The primary outcome was overall survival. RESULTS: A total of 394 operations were performed on 328 patients with 842 tumors undergoing MWA. Median tumor size was 1.5 cm (range 0.4 to 7.0 cm), with the median number of tumors ablated per operation being 1 (range 1 to 11). A laparoscopic approach was used 77.9% of the time. Concomitant procedures were performed 63% of the time, most commonly hepatectomy (22.3%), cholecystectomy (17.5%), and colectomy (6.6%). Clavien-Dindo grade III or IV complication occurred in 12 patients (3.6%), and all of these patients had undergone concomitant procedures. Mortality within 30 days occurred in 4 patients (1.2%). The rate of incomplete ablation was 1.5% per tumor. Local recurrence occurred at a rate of 6.3% per tumor. Black patients were found to have a higher incidence of incomplete ablation and local recurrence. One-year survival probability was 91% (95% CI 87.9 to 94.3), with a mean overall survival of 57.6 months (95% CI 49.9 to 65.4 months). CONCLUSIONS: Surgical MWA offers a low-morbidity approach to treatment of colorectal liver metastasis, with low rate of failure. This large series reviews the outcomes of MWA as definitive treatment for colorectal liver metastasis.
引用
- Wells AB, Butano VW, Phillips MC, et al. Outcomes after Surgical Microwave Ablation for the Treatment of Colorectal Liver Metastasis. J Am Coll Surg. 2024. PMID: 38651746. doi:10.1097/XCS.0000000000001097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。